Sarepta Therapeutics Balance Sheet - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$31.41 $1.25 (3.83%) SRPT stock closing price Jan 23, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Sarepta Therapeutics stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Sarepta Therapeutics stock analysis, and provides insights into the firm's financial performance. A company releases its balance sheet every quarter along with its quarterly results. The Sarepta Therapeutics balance sheet for 2016-Q3 shows total assets of $487.31M. View Sarepta Therapeutics quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Marketable Securities10.69M101.85M122.88M44.09M87.34M91.78M136.79M187.71M180.78M183.34M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets22M16.88M17.38M19.46M23.09M24.41M35.03M26.43M15.9M9.07M
Sarepta Therapeutics Total Current Assets
Property Plant & Equipment64.04M62.8M61.93M60.74M59.38M58.79M58.39M56.04M38.1M37.23M
Accumulated Depreciation28.42M25.82M24.59M23.36M22.19M21.03M19.89M18.86M17.94M17.1M
Sarepta Therapeutics Net Property Plant & Equipment
Investment & Advances0.78M0.78M0.78M11.47M0.78M0.78M0.78M0.64M0.64M0.64M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets8.05M8.14M4.47M7.67M5.31M5.27M2.06M5.72M6.44M0.02M
Sarepta Therapeutics Total Assets
Notes Payable2.49M---------
Accounts Payable20.68M18.67M20.23M7.43M14.09M9.31M12.4M0.96M1.3M7.72M
Current Portion Long-Term Debt10.1M7.6M5.93M3.43M0.1M0.09M0.09M0.09M0.09M0.09M
Current Portion Capital Leases----------
Accrued Expenses29.53M24.27M29.05M19.76M15.18M15.03M17.36M14.82M13.83M16.34M
Income Taxes Payable----------
Other Current Liabilities4.6M4.6M4.57M4.58M4.67M4.61M4.5M4.42M14.16M13.6M
Sarepta Therapeutics Total Current Liabilities
Deferred Taxes/Income5.26M5.86M6.17M6.45M6.72M6.59M6.77M6.36M6.45M7.11M
Convertible Debt----------
Long-Term Debt8.49M13.37M14.96M17.39M20.65M1.45M3.73M3.76M1.52M1.55M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Sarepta Therapeutics Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M-------
Capital Surplus1.49B1.1B1.09B957.6M947.82M941.35M926.76M920.86M905.33M800.52M
Retained Earnings-1.08B-958.82M-899.05M-834.37M-782.43M-740.58M-679.02M-634.6M-605.38M-571.5M
Treasury Stock----------
Other Liabilities--0.01M-0.11M--0.01M-0.01M-0.09M-0.05M-0.03M-0.05M
Sarepta Therapeutics Shareholders Equity
Sarepta Therapeutics Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Looking at Sarepta Therapeutics historical stock prices and the current Sarepta Therapeutics stock price can tell you how the stock price has moved, whereas the Sarepta Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: Anything that the Sarepta Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Sarepta Therapeutics had total assets of $487.31M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. SRPT stock had total liabilities of $78.68M for quarter 2016-Q3.

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio

Quarterly Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, Gilead Sciences balance sheet, Juno Therapeutics balance sheet, Ligand Pharma balance sheet